Showing results (21-30 of 284) with videos related to
Sort By:
Pageof 29
Trends in Cardiovascular Medicine|January 15, 2011
An epidemiologic reassessment of lipoprotein(a) and atherothrombotic riskP M RidkerVascular Medicine (London, England)|July 17, 1998
Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trialP M RidkerCirculation|April 3, 2001
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseP M RidkerAnnals of Internal Medicine|June 22, 1999
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?P M RidkerHaemostasis|January 1, 1997
Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic diseaseP M RidkerClinical Cornerstone|May 9, 2000
Inherited risk factors for venous thromboembolism: implications for clinical practiceP M RidkerBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic viewP M RidkerCirculation|September 17, 1998
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) InvestigatorsP M Ridker, N Rifai, M A Pfeffer, et al.Pageof 29